Combination of antiangiogenic therapy using the mTOR-inhibitor RAD001 and low dose chemotherapy for locally advanced and/or metastatic pancreatic cancer – a dose finding study

Update Il y a 4 ans
Reference: EUCTR2006-003403-39

Woman and Man

  • | Country :
  • -
  • | organs :
  • -
  • | Specialty :
  • -

Extract

To determine the maximum tolerated dose (MTD) and dose-limiting toxicities (DLT) of escalating doses of Gemcitabine in combination with Everolimus.


Inclusion criteria

  • advanced and/or metastatic pancreatic cancer

Links